Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Nadav Sarid"'
Autor:
Ron Ram, Sigal Grisariu, Liat Shargian-Alon, Odelia Amit, Yaeli Bar-On, Polina Stepensky, Moshe Yeshurun, Batia Avni, David Hagin, Chava Perry, Ronit Gurion, Nadav Sarid, Yair Herishanu, Ronit Gold, Chen Glait-Santar, Sigi Kay, Irit Avivi
Publikováno v:
Haematologica, Vol 107, Iss 5 (2021)
Data regarding efficacy and toxicity of chimeric antigen receptor T (CAR-T) cell therapy in the elderly, geriatric population are insufficient. In 2019, tisagenlecleucel and axicabtagene-ciloleucel were commercially approved for relapsed/refractory d
Externí odkaz:
https://doaj.org/article/ee6304dbe547454693562f57a4f69b46
Autor:
Albert Kolomansky, Irit Kaye, Nathalie Ben-Califa, Anton Gorodov, Zamzam Awida, Ofer Sadovnic, Maria Ibrahim, Tamar Liron, Sahar Hiram-Bab, Howard S. Oster, Nadav Sarid, Chava Perry, Yankel Gabet, Moshe Mittelman, Drorit Neumann
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Immunotherapy with anti-CD20-specific antibodies (rituximab), has become the standard of care for B cell lymphoproliferative disorders and many autoimmune diseases. In rheumatological patients the effect of rituximab on bone mass yielded conflicting
Externí odkaz:
https://doaj.org/article/8fe13af2d8c84491be39e81d8606f215
Autor:
Tal Freund, Sarah K. Baxter, Tom Walsh, Hana Golan, Joseph Kapelushnik, Michal Abramsohn-Goldenberg, Shira Benor, Nadav Sarid, Ron Ram, Yifat Alcalay, Reeval Segel, Paul Renbaum, Polina Stepensky, Mary-Claire King, Troy R. Torgerson, David Hagin
Publikováno v:
Journal of Clinical Immunology. 43:151-164
Pathogenic variants in LRBA, encoding the LPS Responsive Beige-Like Anchor (LRBA) protein, are responsible for recessive, early-onset hypogammaglobulinemia, severe multi-organ autoimmunity, and lymphoproliferation, with increased risk for malignancy.
Autor:
Efrat Luttwak, Yafit Segman, May Saban, Odit Gutwein, Irit Avivi, Chava Perry, Alina Filiavich, Nadav Sarid
Publikováno v:
Journal of Medical Screening. 29:255-259
Objective To determine the rate of lymphoproliferative disease (LPD) in women undergoing routine breast cancer screening (BCS). BCS can reveal pathologies other than carcinoma that involve the breast and lymph tissue. The few studies that have descri
Autor:
Irit Avivi, Chava Perry, Yafit Segman, Odelia Amit, Yaeli Bar-On, Ofrat Beyer Katz, Ronit Gold, Elena Ribakovsky, Abraham Avigdor, Vladimir Vainstein, Neta Goldschmidt, Shimrit Ringelstein-Harlev, Netanel A. Horowitz, Odit Gutwein, Ronit Gurion, Gilad Itchaki, Uri Abadi, Anatoly Nemets, Orit Sofer, Miri Vezker, Tamar Tadmor, Najib Dally, Kalman Filanovsky, Merav Leiba, Nadav Sarid, Noam Benyamini, Efrat Luttwak, Yair Herishanu, Ron Ram
Publikováno v:
Annals of Hematology. 101:755-762
Polatuzumab (Pola)-based regimens and chimeric antigen receptor T (CAR T) cells provide superior outcome compared to conventional chemoimmunotherapy in patients with relapsed/refractory diffuse large B cell lymphoma (R/R DLBCL). Choosing between thes
Autor:
Nadav Sarid, Irit Avivi, Chava Perry, Felix Bokstein, Deborah T. Blumenthal, Ahuva Weiss-Meilik, Lili Gibstein, Ron Ram
Publikováno v:
Journal of Neuro-Oncology. 151:211-220
Primary central nervous system lymphoma (PCNSL) is a rare disease with a dismal prognosis compared to its systemic large B-cell lymphoma counterpart. Real world data are limited, when considering a uniform backbone treatment. A retrospective study of
Publikováno v:
British Journal of Haematology. 191:863-867
Cytomegalovirus (CMV) is a ubiquitous virus that infects people worldwide. CMV is known to trigger thrombocytopenia, but this association is probably underdiagnosed since CMV infection in healthy adults is usually either asymptomatic or causes only m
Publikováno v:
Hematological Oncology. 38:223-228
Mantle cell lymphoma (MCL) is a B-cell malignancy, comprising between 3% and 10% of all adult-onset non-Hodgkin lymphomas. MCL is considered incurable with current treatment modalities and most patients require multiple lines of treatment during thei
Autor:
Moshe Mittelman, Yehonatan Sherf, Daniela Goldstein, Tamar Tadmor, Tamar Berger, Reut Harel, Orit Sofer, Eran Zimran, Nagib Dally, Jabour Halloun, Merav Leiba, Gilad Itchaki, Andrei Braester, Maya Koren-Michowitz, Martin Ellis, Nadav Sarid, Shlomzion Aumann, Lev Shvidel, Tsila Zuckerman, Itai Levi, Avital Lavi, Ofer Shpilberg, Ariel Aviv, Noa Lavi, Sharon Ben Barouch, Pia Raanani, Ilana Levy, Katrin Herzog Tzarfati, Sigal Grisariu, Shay Yeganeh, Celia Suriu, Osnat Dolberg Jarchowsky
Publikováno v:
Leukemialymphoma. 62(14)
This national Israeli multicenter retrospective study aimed to characterize the clinical course of COVID-19 infection among patients with hematological malignancies, with special emphasis on treatment efficacy and outcome. Clinical and laboratory dat
Autor:
Noam Benyamini, Inna Passage, Chava Perry, Miriam Neaman, Yair Herishanu, Maayan Jean, Yael C Cohen, Nadav Sarid, Irit Avivi, Shir Mann
Publikováno v:
Patient preference and adherence
Nadav Sarid,1,2 Shir Mann,1 Yair Herishanu,1,2 Chava Perry,1,2 Yael C Cohen,1,2 Inna Passage,1 Miriam Neaman,1,2 Noam Benyamini,1,2 Maayan Jean,1 Irit Avivi1,2 1Departments of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; 2Sackler F